Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk is under pressure from investors for more information about its next-generation ...
Tokyo Electric Power Co. Holdings Inc.-3.65% ¥655.45B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback